April 27, 2026 Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities. More
July 14, 2025 PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala More
April 24, 2025 PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea More
November 19, 2024 PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug. More
